Literature DB >> 16518755

Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever.

Onder Ergonul1, Semra Tuncbilek, Nurcan Baykam, Aysel Celikbas, Basak Dokuzoguz.   

Abstract

We investigated the role played by cytokines in the mortality of patients with Crimean-Congo hemorrhagic fever (CCHF). Serum levels of several cytokines were measured in 3 patients with fatal CCHF and in 27 patients with nonfatal CCHF. Levels of interleukin (IL)-6 (P< or = .001) and tumor necrosis factor (TNF)-alpha (P = .004) were significantly higher in patients with fatal CCHF than in patients with nonfatal CCHF, whereas levels of IL-10 were not significantly different between the 2 groups (P = .937). Disseminated intravascular coagulation (DIC) scores were also higher in the patients with fatal CCHF (P = .023). Levels of IL-6 and TNF-alpha were positively correlated with DIC scores, whereas levels of IL-10 were negatively correlated with DIC scores. In conclusion, these findings demonstrate that proinflammatory cytokines play a major role in the mortality of patients with CCHF.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16518755     DOI: 10.1086/500836

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  57 in total

1.  Crimean-Congo hemorrhagic fever virus activates endothelial cells.

Authors:  Anne-Marie Connolly-Andersen; Guido Moll; Cecilia Andersson; Sara Akerström; Helen Karlberg; Iyadh Douagi; Ali Mirazimi
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Structure, function, and evolution of the Crimean-Congo hemorrhagic fever virus nucleocapsid protein.

Authors:  Stephen D Carter; Rebecca Surtees; Cheryl T Walter; Antonio Ariza; Éric Bergeron; Stuart T Nichol; Julian A Hiscox; Thomas A Edwards; John N Barr
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

3.  Evaluation of cytokines as Th1/Th2 markers in pathogenesis of children with Crimean-Congo hemorrhagic fever.

Authors:  Enver Sancakdar; Ahmet Sami Güven; Elif Bilge Uysal; Ali Kaya; Köksal Deveci; Hekim Karapınar; Ismail Akkar
Journal:  Int J Clin Exp Med       Date:  2014-03-15

Review 4.  Recent advances in research on Crimean-Congo hemorrhagic fever.

Authors:  Anna Papa; Ali Mirazimi; Iftihar Köksal; Augustin Estrada-Pena; Heinz Feldmann
Journal:  J Clin Virol       Date:  2014-10-22       Impact factor: 3.168

5.  Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in Mice.

Authors:  Michael E Lindquist; Xiankun Zeng; Louis A Altamura; Sharon P Daye; Korey L Delp; Candace Blancett; Kayla M Coffin; Jeffrey W Koehler; Susan Coyne; Charles J Shoemaker; Aura R Garrison; Joseph W Golden
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

6.  Establishment of SYBR green-based qPCR assay for rapid evaluation and quantification for anti-Hantaan virus compounds in vitro and in suckling mice.

Authors:  Fei Wei; Jin-lin Li; Jia-xin Ling; Liang-Jun Chen; Ning Li; Yuan-Yuan Liu; Fan Luo; Hai-Rong Xiong; Wei Hou; Zhan-Qiu Yang
Journal:  Virus Genes       Date:  2012-10-10       Impact factor: 2.332

7.  Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality.

Authors:  P Onguru; S Dagdas; H Bodur; M Yilmaz; E Akinci; S Eren; G Ozet
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

8.  Interacting roles of immune mechanisms and viral load in the pathogenesis of crimean-congo hemorrhagic fever.

Authors:  Ana Saksida; Darja Duh; Branka Wraber; Isuf Dedushaj; Salih Ahmeti; Tatjana Avsic-Zupanc
Journal:  Clin Vaccine Immunol       Date:  2010-05-19

9.  Acute arthritis in crimean-congo hemorrhagic Fever.

Authors:  Salih Ahmeti; Lindita Ajazaj-Berisha; Bahrije Halili; Anita Shala
Journal:  J Glob Infect Dis       Date:  2014-04

10.  Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.

Authors:  David W Hawman; Kimberly Meade-White; Elaine Haddock; Rumi Habib; Dana Scott; Tina Thomas; Rebecca Rosenke; Heinz Feldmann
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.